STOCK TITAN
  1. Home
  2. Sec-filings
  3. UTHR
  4. [144] UNITED THERAPEUTICS Corp SEC Filing

199,500-Share Option Exercise; Martine Rothblatt 10b5-1 Sales (UTHR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

UTHR notice shows a planned sale tied to an exercise of stock options: 199,500 shares to be sold on 06/01/2026 for cash. The filing also lists multiple prior 10b5-1 sales by Martine Rothblatt of 9,500 shares on many dates in March–May 2026.

Positive

  • None.

Negative

  • None.

Insights

Notice records an option exercise and routine 10b5-1 dispositions.

The filing documents an exercise of stock options resulting in 199,500 shares being sold on 06/01/2026 for cash. It separately lists numerous 10b5-1 sales by Martine Rothblatt of 9,500 shares on many dates in March–May 2026.

These items are execution events and pre-arranged dispositions shown as completed on the listed dates; cash flows from the option exercise are directed to the issuer per the excerpt. Subsequent filings or confirmations would show final settlement details if provided.

Option exercise shares 199,500 shares exercise of stock options on <date>06/01/2026</date>
Example 10b5-1 sale 9,500 shares 10b5-1 sale on <date>05/29/2026</date> with proceeds <money>$5,261,365.05</money>
Repeated 10b5-1 trade size 9,500 shares recurring 10b5-1 sales by Martine Rothblatt in Mar–May <date>2026</date>
10b5-1 Sales regulatory
"10b5-1 Sales for MARTINE ROTHBLATT 1000 SPRING ST SILVER SPRING MD"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Exercise of Stock Options financial
"Common | 06/01/2026 | Exercise of Stock Options | Issuer"
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the Form 144 for UTHR report?

The Form 144 reports an exercise of stock options for 199,500 shares to be sold on 06/01/2026. It also lists multiple 10b5-1 sales by Martine Rothblatt of 9,500 shares on various March–May 2026 dates.

Who conducted the 10b5-1 sales listed in the filing for UTHR?

The excerpt identifies Martine Rothblatt as the participant in numerous 10b5-1 sales of 9,500 shares on multiple dates between March and May 2026. Each sale is shown with trade date and gross cash amount.

How many shares were exercised and how were proceeds handled?

The filing shows an option exercise of 199,500 shares with the method listed as Cash, indicating the issuer received cash proceeds from that exercise on 06/01/2026 according to the excerpt.

Do the listed 10b5-1 entries indicate routine or discretionary trades?

The filing labels those transactions as 10b5-1 Sales, which are pre-arranged trading plans. The entries show repeated 9,500-share sales across March–May 2026, consistent with scheduled dispositions rather than ad-hoc trades.